Symptomatic Nursing Management of Advanced Breast Cancer with Multiple Metastases During DS-8201 Treatment: A Case Report and Literature Review

Na Liu,1,* Chunhua Zhao,2 Dan Li,1,* Siqi Liu,1 Hongyan Sun2 1Department of Breast, Electric Power Hospital, Beijing, 100073, People’s Republic of China; 2Nursing Department, Electric Power Hospital, Beijing, 100073, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chunhua Zhao, Nursing Department, Electric Power Hospital, No. 1 Xilijia, Taipingqiao, Fengtai District, Beijing, 100073, People’s Republic of China, Tel +86-010-63501188, Email [email protected]: To summarise the therapeutic effects of symptomatic nursing during DS-8201 (Enhertu) treatment in a patient with advanced breast cancer with metastases to the ribs, lungs and liver. The patient, diagnosed with breast cancer with multiple metastases, was admitted to the hospital on 4 January 2021, 2 months after the discovery of a right breast mass. DS-8201 was administered during this period, and nursing care was tailored to address the patient’s symptoms while on the medication. Before treatment, the Hamilton Anxiety Scale score was 22, the Pittsburgh Sleep Quality Index score was 19 and the Insomnia Severity Index score was 24. After treatment, the SAS score decreased to 15, the PSQI score to 12 and the ISI score to 11, indicating improvements in sleep quality and anxiety. Re-examination showed minimal change in left breast nodules compared with previous results, with no additional metastases detected. By the follow-up in September 2023, the patient showed no signs of obvious recurrence and had not returned to the hospital for further consultation. During a telephone follow-up in October 2023, the patient reported no significant discomfort, her condition remained stable and her health indicators were well controlled while on the medication. This study details the symptoms and corresponding nursing interventions for patients with advanced breast cancer undergoing DS-8201 treatment, providing a nursing reference for future patient care.Keywords: breast cancer, multiple metastases, Enhertu, nursing

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2024-12-01
Primary Topic
Liquid Crystal Research Advancements
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Symptomatic Nursing Management of Advanced Breast Cancer with Multiple Metastases During DS-8201 Treatment: A Case Report and Literature Review

SHILAP Revista de lepidopterología
Liquid Crystal Research Advancements
article

Symptomatic Nursing Management of Advanced Breast Cancer with Multiple Metastases During DS-8201 Treatment: A Case Report and Literature Review

article en

Abstract

Na Liu,1,* Chunhua Zhao,2 Dan Li,1,* Siqi Liu,1 Hongyan Sun2 1Department of Breast, Electric Power Hospital, Beijing, 100073, People’s Republic of China; 2Nursing Department, Electric Power Hospital, Beijing, 100073, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chunhua Zhao, Nursing Department, Electric Power Hospital, No. 1 Xilijia, Taipingqiao, Fengtai District, Beijing, 100073, People’s Republic of China, Tel +86-010-63501188, Email [email protected]: To summarise the therapeutic effects of symptomatic nursing during DS-8201 (Enhertu) treatment in a patient with advanced breast cancer with metastases to the ribs, lungs and liver. The patient, diagnosed with breast cancer with multiple metastases, was admitted to the hospital on 4 January 2021, 2 months after the discovery of a right breast mass. DS-8201 was administered during this period, and nursing care was tailored to address the patient’s symptoms while on the medication. Before treatment, the Hamilton Anxiety Scale score was 22, the Pittsburgh Sleep Quality Index score was 19 and the Insomnia Severity Index score was 24. After treatment, the SAS score decreased to 15, the PSQI score to 12 and the ISI score to 11, indicating improvements in sleep quality and anxiety. Re-examination showed minimal change in left breast nodules compared with previous results, with no additional metastases detected. By the follow-up in September 2023, the patient showed no signs of obvious recurrence and had not returned to the hospital for further consultation. During a telephone follow-up in October 2023, the patient reported no significant discomfort, her condition remained stable and her health indicators were well controlled while on the medication. This study details the symptoms and corresponding nursing interventions for patients with advanced breast cancer undergoing DS-8201 treatment, providing a nursing reference for future patient care.Keywords: breast cancer, multiple metastases, Enhertu, nursing

SHILAP Revista de lepidopterología
Good health and well-being
Openalex Percentile: Top 74%
Liquid Crystal Research Advancements
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Symptomatic Nursing Management of Advanced Breast Cancer with Multiple Metastases During DS-8201 Treatment: A Case Report and Literature Review · SHILAP Revista de lepidopterología (2024) | TGRS Research Map | TGRS